Allosteric modulation of the human 5-HT7A receptor by lipidic amphipathic compounds

被引:29
作者
Alberts, GL [1 ]
Chio, CL [1 ]
Im, WB [1 ]
机构
[1] Pharmacia & Upjohn Inc, Unit 7251, Dept Biol Neurobiol 2, Kalamazoo, MI 49007 USA
关键词
D O I
10.1124/mol.60.6.1349
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Human 5-HT7A receptors positively modulated adenylyl cyclases via G(s) subtypes of G proteins in human embryonic kidney 293 cells, and bound 5-hydroxytryptamine (HT) with high and low affinity (K-1 values of 1.5 +/- 0.3 and 93 +/- 4 nM). More than 60% of 5-HT7A receptors, however, displayed the high-affinity 5-HT binding with no sensitivity to 5'-guanylylimidodiphosphate. In this study, we found that select amphipathic agents affected the high-affinity 5-HT binding to 5-HT7A. Oleic acid at low concentrations (<15 <mu>M), but not palmitic, stearic, and arachidonic acids, increased maximal [H-3]5-HT binding without affecting its K-D value and [H-3]mesulergine (antagonist) binding. Fatty acid-free bovine serum albumin (FF-BSA), a scavenger of fatty acids and lipid metabolites, substantially reduced maximal [H-3]5-HT binding (no change in K-D value and antagonist binding) but lost its action upon treatment with inactive stearic acid. FF-BSA and oleic acid produced no appreciable effects on [H-3]5-HT binding to analogous 5-HT receptors 5-HT1D and 5-H-2C. Among various lysophospholipids, lysophosphatidyl choline (50 muM) decreased maximal [H-3]5-HT binding, and a similar zwitterion, 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate (CHAPS; 0.1%), increased it (no change in K-D). Functionally, 5-HT-induced guanosine-5'-O-(3-[S-35]thio)-triphosphate (GTP-gamma S-35) binding was enhanced by oleic acid and CHAPS, but reduced by FF-BSA and lysophosphatidyl choline; the amphipathic agents and FF-BSA did not affect dopamine-induced GTP gamma S-35 binding at D1, a prototypic G(s)-coupled receptor. At 5-HT7A, oleic acid, FF-BSA, CHAPS, and lysophosphatidyl choline also brought about corresponding changes in the half-maximal 5-HT concentration for cAMP production, without affecting the maximal and basal levels. We propose that endogenous, amphipathic lipid metabolites may modulate 5-HT7A receptors allosterically to promote high-affinity 5-HT binding and to enable receptors to couple more efficiently to G(s) subtypes of G proteins.
引用
收藏
页码:1349 / 1355
页数:7
相关论文
共 26 条
  • [1] Adham N, 1998, J PHARMACOL EXP THER, V287, P508
  • [2] Agonist-induced GTPγ35S binding mediated by human 5-HT2C receptors expressed in human embryonic kidney 293 cells
    Alberts, GL
    Pregenzer, JF
    Im, WB
    Zaworski, PG
    Gill, GS
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1999, 383 (03) : 311 - 319
  • [3] BARD JA, 1993, J BIOL CHEM, V268, P23422
  • [4] CHABERT C, 1994, J NEUROCHEM, V63, P62
  • [5] CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099
  • [6] Cushing DJ, 1996, J PHARMACOL EXP THER, V277, P1560
  • [7] Allosteric regulation by oleamide of the binding properties of 5-hydroxytryptamine7 receptors
    Hedlund, PB
    Carson, MJ
    Sutcliffe, JG
    Thomas, EA
    [J]. BIOCHEMICAL PHARMACOLOGY, 1999, 58 (11) : 1807 - 1813
  • [8] Function and distribution of three rat 5-hydroxytryptamine7 (5-HT7) receptor isoforms produced by alternative splicing
    Heidmann, DEA
    Szot, P
    Kohen, R
    Hamblin, MW
    [J]. NEUROPHARMACOLOGY, 1998, 37 (12) : 1621 - 1632
  • [9] Heidmann DEA, 1997, J NEUROCHEM, V68, P1372
  • [10] Cloning, expression and pharmacology of a truncated splice variant of the human 5-HT7 receptor (h5-HT7(b))
    Jasper, JR
    Kosaka, A
    To, ZP
    Chang, DJ
    Eglen, RM
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1997, 122 (01) : 126 - 132